|
Real Estate News Releases
|
(EMAILWIRE.COM, December 30, 2010 ) Boston, MA - InsiderCow.com: JORDEN DAVID EMERSON, director of CYTOMEDIX INC (AMEX: GTF) bought 12,500 shares of GTF from the open market on 2010-12-28 according to an SEC filing reported by insidercow.com at 2010-12-28 10:08:31 ET. The stock was up 6.25% after the InsiderCow.com report.
Trade amount: 12,500 Shares
Trade type: Open Market Buy
Price Range: $0.47
Transaction details can be found at http://www.insidercow.com/history/company.jsp?company=GTF You can also get real-time alert on any insider trading information from www.insidercow.com, one step step before everybody else.
About InsiderCow.com
InsiderCow.com is a leading real-time insider trading information provider. InsiderCow.com is the online division of InsiderCow, a privately-owned company specialized in insider trading information. InsiderCow uses its proprietary software to gather and analyze information provided by the U.S. Securities and Exchange Commission, in real-time. For more information about InsiderCow.com, visit www.insidercow.com.
About GTF:
Cytomedix, Inc., a biotechnology company, engages in the development, sale, and licensing of regenerative biological therapies for wound care, inflammation, and angiogenesis in the United States.
Disclosure: Insidercow.com is not a registered investment advisers or broker/dealer. Insidercow.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable.
CONTACT: InsiderCow.com
e-mail: support@insidercow.com
WWW: http://www.insidercow.com
InsiderCow
Kevin Leng
781-526-8657
support@insidercow.com
|
|
|
Real Estate News by Sector
|
|
|
|